Overview

Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

Status:
RECRUITING
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this prospective, randomized, double-blinded study is to further evaluate the safety and efficacy of varying doses of intravenous magnesium in the treatment of AFF RVR.
Phase:
PHASE3
Details
Lead Sponsor:
Wake Forest University Health Sciences
Treatments:
Magnesium Sulfate
Sodium Chloride